Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.50$ +0.8% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Elanco Animal Health (ELAN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 13,561 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELAN
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	8,100	–	–	8,940	8,940	8,577	8,577	9,212	8,957	8,747	8,857	8,824	8,986	9,727	9,876	17,237	17,693	16,988	16,833	16,565	16,478	16,251	15,601	14,948	15,491	15,769	15,796	14,344	14,362	14,019	13,764	13,283	12,614	12,941	13,742	13,551	13,358	13,222	13,561
Current Assets	1,947	259	–	2,124	2,124	323	2,057	2,704	2,505	2,278	2,384	2,310	2,373	3,121	3,191	3,281	3,417	3,344	3,431	3,160	3,274	3,194	3,307	3,154	3,279	3,548	3,652	3,565	3,407	4,050	4,011	3,366	3,215	3,440	3,614	3,493	3,458	3,584	3,797
Cash	259	-259	–	323	323	-323	321	300	475	272	385	309	334	1,206	1,391	660	495	515	580	453	638	342	507	460	345	318	367	369	352	345	416	490	468	487	539	505	545	428	530
Cash & Short-Term Investments	–	259	–	–	323	323	321	300	475	272	385	309	334	1,206	1,391	660	495	515	580	453	638	342	507	460	345	318	367	369	352	345	416	490	468	487	539	505	545	428	530
Receivables	631	–	–	602	602	624	624	637	709	827	832	823	890	752	617	833	1,077	1,132	1,174	1,082	1,028	1,192	1,128	1,028	1,002	1,264	1,225	1,135	1,010	1,078	1,080	904	886	1,060	1,103	975	940	1,154	1,152
Inventory	876	–	–	1,062	1,062	1,006	1,006	1,009	1,004	1,036	1,053	1,069	1,051	1,019	1,065	1,597	1,578	1,424	1,450	1,383	1,371	1,345	1,334	1,340	1,538	1,596	1,690	1,690	1,735	1,638	1,611	1,632	1,574	1,592	1,670	1,708	1,737	1,717	1,769
Property, Plant & Equipment	742	–	–	920	920	878	878	909	922	1,011	1,012	993	1,040	930	952	1,243	1,316	1,271	1,033	1,041	1,222	987	961	936	999	1,000	1,007	992	–	–	–	–	–	–	–	–	–	–	–
Goodwill	2,577	–	–	2,969	2,969	2,932	2,932	2,969	2,958	2,933	2,960	2,946	2,990	3,004	3,044	6,435	6,225	6,016	6,239	6,191	6,172	6,116	5,898	5,716	5,993	6,061	6,040	4,902	5,094	4,478	4,480	4,625	4,414	4,508	4,758	4,764	4,779	4,723	4,845
Intangible Assets	5,198	–	–	2,673	2,673	2,535	2,535	2,515	2,453	2,387	2,353	2,435	2,483	2,456	2,433	5,786	6,387	6,032	5,755	5,816	5,587	5,395	5,059	4,766	4,842	4,791	4,678	4,475	4,494	4,196	4,000	4,011	3,681	3,634	3,705	3,596	3,408	3,225	3,204
Total Liabilities	1,072	–	–	1,150	1,150	991	991	4,074	3,759	3,551	3,591	3,336	3,439	3,066	3,224	8,893	9,217	8,981	8,853	8,883	8,970	8,639	8,461	8,203	8,202	8,289	8,376	8,210	8,139	7,963	7,822	6,760	6,518	6,588	6,967	6,802	6,811	6,722	6,973
Current Liabilities	619	–	–	633	633	558	558	1,245	971	708	778	742	819	708	835	1,871	2,077	2,034	1,990	1,362	1,647	1,307	1,338	1,613	1,702	1,578	1,284	1,265	1,241	1,232	1,370	1,321	1,315	1,269	1,392	1,455	1,597	1,662	1,852
Short-Term Debt	–	–	–	–	–	–	–	–	29	51	50	49	25	26	26	554	555	605	555	61	294	61	56	394	388	381	39	39	38	38	213	44	44	44	61	62	74	73	73
Accounts Payable	228	–	–	204	204	194	194	203	205	252	243	206	223	215	243	356	501	411	506	436	416	402	386	350	390	381	354	296	270	302	291	259	296	330	368	352	368	372	427
Long-Term Debt	–	–	–	–	–	–	–	2,479	2,443	2,437	2,382	2,336	2,331	2,036	2,030	5,587	5,572	5,556	5,542	6,273	6,025	6,073	6,007	5,507	5,448	5,639	6,023	5,870	5,736	5,727	5,463	4,313	4,277	4,351	4,148	3,962	3,943	3,918	3,845
Shareholders' Equity	7,028	7,028	–	7,791	7,791	7,780	7,587	5,137	5,198	5,196	5,266	5,488	5,547	6,662	6,652	8,344	8,476	8,007	7,980	7,682	7,508	7,612	7,140	6,745	7,289	7,480	7,420	6,134	6,223	6,056	5,942	6,523	6,096	6,353	6,775	6,749	6,547	6,500	6,588
Retained Earnings	–	–	–	–	–	–	–	0.0	16	48	84	94	84	34	-19	-154	-477	-538	-748	-852	-979	-901	-923	-972	-1,057	-954	-1,051	-2,147	-2,288	-2,256	-2,306	-1,942	-1,950	-1,883	-1,872	-1,906	-2,182	-2,125	-2,071
Shares Outstanding	–	361	361	366	366	356	356	366	366	366	367	373	375	404	413	462	486	487	487	487	487	492	488	488	489	493	493	493	493	496	494	498	494	499	500	497	497	506	506

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings